Nu Skin Enterprises Inc (NUS)

Debt-to-assets ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 478,040 362,896 367,753 372,609 377,466 382,323 387,179 258,995 268,781 278,563 288,343 298,120 305,393 312,664 319,932 327,197 334,461 341,724 348,986 356,247
Total assets US$ in thousands 1,806,460 1,793,090 1,893,780 1,824,640 1,820,970 1,763,170 1,900,900 1,892,250 1,906,480 1,974,410 2,049,980 1,950,100 1,957,080 1,816,710 1,794,490 1,746,320 1,769,010 1,736,900 1,791,100 1,755,100
Debt-to-assets ratio 0.26 0.20 0.19 0.20 0.21 0.22 0.20 0.14 0.14 0.14 0.14 0.15 0.16 0.17 0.18 0.19 0.19 0.20 0.19 0.20

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $478,040K ÷ $1,806,460K
= 0.26

The debt-to-assets ratio provides insight into the proportion of a company's assets that are financed through debt. In the case of Nu Skin Enterprises, Inc., the trend in the debt-to-assets ratio over the past eight quarters shows a relatively stable pattern with some fluctuations.

The debt-to-assets ratio ranged from 0.20 to 0.28 during the period analyzed. A ratio of 0.20 indicates that for every $1 of assets, the company had $0.20 in debt, while a ratio of 0.28 implies $0.28 in debt for every $1 of assets.

The company maintained a conservative approach to debt financing, as the ratios remained relatively low throughout the quarters. The slight fluctuations observed may be due to various factors such as changes in the company's capital structure, borrowing activities, or asset management strategies.

Overall, Nu Skin Enterprises, Inc. appears to have effectively managed its debt relative to its assets, maintaining a healthy balance between debt and equity in its capital structure.


Peer comparison

Dec 31, 2023

Company name
Symbol
Debt-to-assets ratio
Nu Skin Enterprises Inc
NUS
0.26
Cardinal Health Inc
CAH
0.00
Cencora Inc.
COR
0.06
McKesson Corporation
MCK
0.00